Positive and negative influences of regulatory T cells on tumour immunity
被引:0
|
作者:
A M Gallimore
论文数: 0引用数: 0
h-index: 0
机构:School of Medicine,Department of Medical Biochemistry and Immunology
A M Gallimore
A K Simon
论文数: 0引用数: 0
h-index: 0
机构:School of Medicine,Department of Medical Biochemistry and Immunology
A K Simon
机构:
[1] School of Medicine,Department of Medical Biochemistry and Immunology
[2] Cardiff University,Nuffield Department of Medicine
[3] NIHR Biomedical Research Centre,undefined
[4] Weatherall Institute of Molecular Medicine,undefined
[5] John Radcliffe Hospital,undefined
来源:
Oncogene
|
2008年
/
27卷
关键词:
tumour;
cancer;
regulatory T cells;
development of regulatory T cells;
Th17;
Il-23;
D O I:
暂无
中图分类号:
学科分类号:
摘要:
Clinicians and scientists have long questioned whether the immune system has a role in destroying cancerous tissue. Studies performed in animal models have, however, recently revealed that the immune system can, at least in principle, effectively control tumours. In parallel with these findings, a large body of evidence indicates that although the immune system has the capacity to control tumours, there are also regulatory mechanisms that subdue these responses. A major challenge of tumour immunotherapy, therefore, is to find ways of disabling these regulatory functions while restoring or priming any immune responses that are protective.